Physician profile
Dilli Ram Poudel
NPI 1275940041
$6,594.28
in general payments reported to CMS, 2019-2025
21 companies · $78.08 in 2025
The $78.08 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $266 · 2021: $957 · 2022: $1,711 · 2023: $2,325 · 2024: $1,258 · 2025: $78.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,313 · Education: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,312.64 |
| Education | $347.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,294.43 | 2021-2024 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $1,051.21 | 2021-2024 | |
| Amgen INC. | $839.48 | 2020-2024 | Otezla, Enbrel, Tavneos |
| Ucb, INC. | $815.71 | 2020-2024 | Cimzia |
| Glaxosmithkline, LLC. | $500.62 | 2020-2024 | Benlysta |
| Pfizer INC. | $457.39 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $415.19 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $298.56 | 2022-2024 | Saphnelo |
| Sobi, INC | $199.64 | 2021-2024 | |
| Lilly USA, LLC | $171.44 | 2021-2024 | Taltz |
| Cardinal Health 110 LLC | $100.00 | 2022 | |
| Horizon Therapeutics Plc | $79.17 | 2020-2022 | |
| Genzyme Corporation | $78.08 | 2025 | |
| Sandoz INC. | $61.24 | 2024 | Hyrimoz |
| Fresenius Kabi USA, LLC | $59.19 | 2023-2024 | Idacio |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $43.92 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Alexion Pharmaceuticals, INC. | $40.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.49 | 2024 | Cyltezo, Ofev |
| Mallinckrodt Hospital Products INC. | $19.49 | 2022 | |
| Halozyme INC | $18.27 | 2023 | |
| Orthofix Medical, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilli Poudel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.